Green Cross teams up with IPK on screening of new drugs

Published: 2012-12-13 07:00:00

Updated: 2012-12-13 07:00:00

Green Cross Corp. said Tuesday that it has entered into a collaborative agreement with Institut Pasteur Korea (IPK), centered on the establishment of a compound library, for the identification and development of safe, effective and affordable new treatments for patients suffering from cancer or r...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK